{
    "organizations": [],
    "uuid": "4b6c51591a7f3805c08e17d6c68e258907db082f",
    "author": "",
    "url": "https://www.reuters.com/article/brief-sangamo-and-pfizer-announce-collab/brief-sangamo-and-pfizer-announce-collaboration-for-development-of-zinc-finger-protein-gene-therapy-for-als-idUSFWN1OY0C2",
    "ord_in_thread": 0,
    "title": "BRIEF-Sangamo And Pfizer Announce Collaboration For Development Of Zinc Finger Protein Gene Therapy For Als",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 37 PM / Updated 19 minutes ago BRIEF-Sangamo And Pfizer Announce Collaboration For Development Of Zinc Finger Protein Gene Therapy For Als Reuters Staff \nJan 3 (Reuters) - Pfizer Inc: \n* SANGAMO AND PFIZER ANNOUNCE COLLABORATION FOR DEVELOPMENT OF ZINC FINGER PROTEIN GENE THERAPY FOR ALS \n* SANGAMO THERAPEUTICS​ - CO, ‍PFIZER ANNOUNCED COLLABORATION FOR DEVELOPMENT OF ZINC FINGER PROTEIN GENE THERAPY FOR ALS \n* SANGAMO THERAPEUTICS INC - UNDER TERMS OF COLLABORATION AGREEMENT, SANGAMO WILL RECEIVE A $12 MILLION UPFRONT PAYMENT FROM PFIZER \n* SANGAMO THERAPEUTICS INC - UNDER AGREEMENT, CO ‍WILL BE RESPONSIBLE FOR DEVELOPMENT OF ZFP-TF CANDIDATES​ \n* SANGAMO - UNDER TERMS ELIGIBLE TO RECEIVE POTENTIAL DEVELOPMENT & COMMERCIAL MILESTONE PAYMENTS UP TO $150 MILLION, TIERED ROYALTIES ON NET SALES \n* SANGAMO - UNDER DEAL,‍PFIZER OPERATIONALLY,FINANCIALLY RESPONSIBLE FOR RESEARCH,DEVELOPMENT,COMMERCIALIZATION FOR C9ORF72 ZFP-TF,RESULTING PRODUCTS Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T14:36:00.000+02:00",
    "crawled": "2018-01-03T14:58:40.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pfizer",
        "announce",
        "collaboration",
        "development",
        "zinc",
        "finger",
        "protein",
        "gene",
        "therapy",
        "al",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "pfizer",
        "inc",
        "sangamo",
        "pfizer",
        "announce",
        "collaboration",
        "development",
        "zinc",
        "finger",
        "protein",
        "gene",
        "therapy",
        "al",
        "sangamo",
        "co",
        "announced",
        "collaboration",
        "development",
        "zinc",
        "finger",
        "protein",
        "gene",
        "therapy",
        "al",
        "sangamo",
        "therapeutic",
        "inc",
        "term",
        "collaboration",
        "agreement",
        "sangamo",
        "receive",
        "million",
        "upfront",
        "payment",
        "pfizer",
        "sangamo",
        "therapeutic",
        "inc",
        "agreement",
        "co",
        "responsible",
        "development",
        "sangamo",
        "term",
        "eligible",
        "receive",
        "potential",
        "development",
        "commercial",
        "milestone",
        "payment",
        "million",
        "tiered",
        "royalty",
        "net",
        "sale",
        "sangamo",
        "deal",
        "operationally",
        "financially",
        "responsible",
        "research",
        "development",
        "commercialization",
        "c9orf72",
        "resulting",
        "product",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}